Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy

  1. Burgaz, S.
  2. Navarro, E.
  3. Rodríguez-Carreiro, S.
  4. Navarrete, C.
  5. Garrido-Rodríguez, M.
  6. Lastres-Becker, I.
  7. Chocarro, J.
  8. Lanciego, J.L.
  9. Muñoz, E.
  10. Fernández-Ruiz, J.
Revista:
Behavioral and Brain Functions

ISSN: 1744-9081

Ano de publicación: 2024

Volume: 20

Número: 1

Tipo: Artigo

DOI: 10.1186/S12993-024-00256-9 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus